首页> 外文期刊>Contrast media & molecular imaging >Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design
【24h】

Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design

机译:基于逆电子DIELS-ALDER反应的预注算核影像疗法和预注算的合成设计中的关键因素

获取原文
           

摘要

The exceptional speed and biorthogonality of the inverse electron-demand Diels–Alder (IEDDA) click chemistry between 1,2,4,5-tetrazines and strained alkene dienophiles have made it promising in the realm of pretargeted imaging and therapy. During the past 10?years, the IEDDA-pretargeted strategies have been tested and have already proven capable of producing images with high tumor-to-background ratios and improving therapeutic effect. This review will focus on recent applications of click chemistry ligations in the pretargeted imaging studies of single photon emission computed tomography (SPECT), positron emission tomography (PET), and pretargeted radioimmunotherapy investigations. Additionally, the influence factors of stability, reactivity, and pharmacokinetic properties of TCO tag modified immunoconjugates and radiolabeled Tz derivatives were also summarized in this article, which should be carefully considered in the system design in order to develop a successful pretargeted methodology. We hope that this review will not only equip readers with a knowledge of pretargeted methodology based on IEDDA click chemistry but also inspire synthetic chemists and radiochemists to develop pretargeted radiopharmaceutical components in a more innovative way with various influence factors considered.
机译:逆氧化Diels-Alder(IEDDA)的卓越速度和双健康性点击1,2,4,5-四嗪和应变的烯烃辅助烯烃之间的化学使其在预靶向成像和治疗的领域中承诺。在过去的10年中,已经测试了IEDDA - 预注算的策略,并且已经证明能够产生具有高肿瘤到背景比率的图像并提高治疗效果。本综述将重点关注最近在单光子发射计算机断层扫描(SPECT),正电子发射断层扫描(PET)和预注射放射免疫疗法调查中的预靶向成像研究中的近期化学连接。另外,在本文中还总结了TCO标签改性免疫缀合物和放射性标记的TZ衍生物的稳定性,反应性和药代动力学性能的影响因素,并且在系统设计中应仔细考虑,以开发成功的预注算方法。我们希望本综述不仅将读者提供基于IEDDA点击化学的预注算方法知识,而且还激发了合成化学家和放射化学家,以更具创新的方式开发预注算的放射性药物组分,以更具影响因素所考虑的各种影响因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号